We are live on ! Find out more
ONC

BeOne Medicines Ltd

192 hedge funds and large institutions have $6.65B invested in BeOne Medicines Ltd in 2018 Q4 according to their latest regulatory filings, with 82 funds opening new positions, 65 increasing their positions, 30 reducing their positions, and 32 closing their positions.

New
Increased
Maintained
Reduced
Closed

156% more first-time investments, than exits

New positions opened: 82 | Existing positions closed: 32

140% more call options, than puts

Call options by funds: $50.8M | Put options by funds: $21.1M

117% more repeat investments, than reductions

Existing positions increased: 65 | Existing positions reduced: 30

56% more funds holding in top 10

Funds holding in top 10: 914 (+5)

33% more funds holding

Funds holding: 144192 (+48)

0.23% more ownership

Funds ownership: 5.95%6.18% (+0.23%)

15% less capital invested

Capital invested by funds: $7.84B → $6.65B (-$1.19B)

Holders
192
Holders Change
+48
Holders Change %
+33.33%
% of All Funds
4.28%
Holding in Top 10
14
Holding in Top 10 Change
+5
Holding in Top 10 Change %
+55.56%
% of All Funds
0.31%
New
82
Increased
65
Reduced
30
Closed
32
Calls
$50.8M
Puts
$21.1M
Net Calls
+$29.6M
Net Calls Change
+$49.2M
Name Holding Trade Value Shares
Change
Change in
Stake
Stifel Financial
126
Stifel Financial
Missouri
$538K +$37.4K +282 +8%
JGGDR
127
JGP Global Gestao de Recursos
Brazil
$527K +$498K +3,757 New
Comerica Bank
128
Comerica Bank
Texas
$522K +$144K +1,083 +35%
FAF
129
Fjarde Ap-fonden
Sweden
$505K +$477K +3,600 New
Mackenzie Financial
130
Mackenzie Financial
Ontario, Canada
$497K +$470K +3,546 New
COPPSERS
131
Commonwealth of Pennsylvania Public School Employees Retirement System
Pennsylvania
$490K +$463K +3,490 New
Mitsubishi UFJ Asset Management
132
Mitsubishi UFJ Asset Management
Japan
$482K +$498K +3,758 New
Group One Trading
133
Group One Trading
Illinois
$452K +$14.3K +108 +3%
NIPH
134
NN Investment Partners Holdings
Netherlands
$452K +$427K +3,217 New
RJA
135
Raymond James & Associates
Florida
$428K +$63.1K +476 +18%
PI
136
PEAK6 Investments
Illinois
$407K +$6.5K +49 +2%
AG
137
Aperio Group
California
$401K +$380K +2,862 New
OAM
138
Oppenheimer Asset Management
New York
$399K -$398 -3 -0.1%
Jane Street
139
Jane Street
New York
$385K -$824K -6,216 -69%
BC
140
Brinker Capital
Pennsylvania
$375K -$151K -1,139 -30%
KBC Group
141
KBC Group
Belgium
$368K +$348K +2,622 New
NAM
142
Nissay Asset Management
Japan
$368K +$348K +2,626 New
Toronto Dominion Bank
143
Toronto Dominion Bank
Ontario, Canada
$365K +$345K +2,600 New
SG Americas Securities
144
SG Americas Securities
New York
$359K +$340K +2,563 New
Principal Financial Group
145
Principal Financial Group
Iowa
$351K +$332K +2,505 New
MIM
146
MetLife Investment Management
New Jersey
$337K +$318K +2,400 New
VEA
147
Virtus ETF Advisers
New York
$316K -$52.9K -399 -15%
Prudential Financial
148
Prudential Financial
New Jersey
$316K +$299K +2,255 New
CIBC Asset Management
149
CIBC Asset Management
Ontario, Canada
$298K +$282K +2,128 New
Daiwa Securities Group
150
Daiwa Securities Group
Japan
$288K +$247K +1,860 +954%

ONC Hedge Fund Activity: Q4 2018 in Review

192 of the 4,488 institutional investors tracked by Wall St. Rank reported a position in BeOne Medicines Ltd (ONC) for Q4 2018, worth a combined $6.65B — down 15% from $7.84B a quarter earlier.

Buyers outnumbered sellers: 82 funds opened new ONC positions and 32 closed out — a net gain of 50 holders — while 65 added to existing stakes and 30 trimmed.

The largest buyer was BlackRock, adding an estimated $186M. The largest seller was Hillhouse Investment Management, cutting an estimated $589M.

  • 192 institutional investors held BeOne Medicines Ltd (ONC) as of Q4 2018, up from 144 in Q3 2018.
  • Funds reported $6.65B of BeOne Medicines Ltd stock for Q4 2018, down 15% quarter-over-quarter.
  • 82 funds opened new BeOne Medicines Ltd positions in Q4 2018 and 32 closed out, a net change of +50 holders.
  • The largest BeOne Medicines Ltd buyer in Q4 2018 was BlackRock, an estimated $186M added.
  • The largest BeOne Medicines Ltd seller in Q4 2018 was Hillhouse Investment Management, an estimated $589M sold.

Based on aggregated 13F filings for Q4 2018.